Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Norgine appoints global quality director

September 16, 2010 Manufacturing and Production, Research and Development Norgine, appointment, manufacturing and production, research and development

Rosemarie Corrigan has joined European specialty pharmaceutical company Norgine as director of global quality, taking a leadership role across a …
Appointment

Gene therapy advance hailed for thalassemia

September 16, 2010 Research and Development Bluebird Bio, gene therapy, thalassemia

A new gene therapy for one of the most frequently inherited genetic disorders has produced promising results. The trial by …
News

Novo expands diabetes research in China

September 16, 2010 Research and Development China, Novo Nordisk, diabetes

Diabetes is at the core of Novo Nordisk’s latest investment in China, where the company plans to more than double …
News

Pepscan and Tibotec sign peptides deal

September 15, 2010 Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec

Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …
News

Positive results for irritable bowel syndrome drug

September 14, 2010 Research and Development Almirall, IBS, linaclotide

A new treatment for patients with irritable bowel syndrome with constipation has produced promising results in a phase III trial. …
News

Future of Roche diabetes trial uncertain

September 14, 2010 Research and Development GLP-1, Roche, taspoglutide

Roche has admitted it does not know when phase III trials of the investigational type II diabetes drug taspoglutide will …
News

Genzyme planning 1,000 job cuts

September 14, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, job cuts

Genzyme has said it intends to cut back its workforce by around 1,000 over the next 15 months in order …
News

Zactima extends progression free survival in other thyroid cancers

September 13, 2010 Research and Development thyroid cancer, zactima

New data suggests patients with the more common forms of thyroid cancer respond to AstraZeneca’s Zactima. The drug has already …
News

AZ signs cancer development deal

September 13, 2010 Research and Development AstraZeneca, CRT, Cancer Research UK

AstraZeneca has agreed a deal with charity Cancer Research UK to develop a first-in-class cancer treatment. AZD-3965 targets the monocarboxylate …
News

Transgene acquires rights to cancer vaccine

September 10, 2010 Research and Development JX-594, Jennerex, Transgene, cancer vaccine

French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …
News

GSK paves way for biopharmaceuticals growth

September 9, 2010 Research and Development GlaxoSmithKline, Lonza, biologics

GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …
News

Universities attack European research grant

September 9, 2010 Research and Development EFPIA, IMI, Innovative Medicines Initiative, academia

A European initiative aimed at fostering new medical research is neglecting its public partners in favour of its private ones, …
News

EU set to pass stricter laws for experiments on animals

September 9, 2010 Research and Development Animal testing, Animal tests

The number of animals used in scientific experiments will be reduced under new EU legislation agreed by the European Parliament …
News

Tzvi Palash joins Protalix BioTherapeutics

September 9, 2010 Manufacturing and Production, Research and Development Portalix BioTherapeutics, appointment, manufacturing and production, research and development

Protalix BioTherapeutics has appointed Tzvi Palash to the newly-created position of chief operating officer. He will be responsible for overseeing …
Appointment
Andreotti

BMS to acquire ZymoGenetics

September 8, 2010 Research and Development, Sales and Marketing BMS, hepatitis

 Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026